scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41371-019-0166-2 |
P698 | PubMed publication ID | 30647466 |
P50 | author | Vahidreza Ostadmohammadi | Q61089675 |
Zahra Keshtkaran | Q86301951 | ||
P2093 | author name string | Russel J Reiter | |
Zatollah Asemi | |||
Reza Tabrizi | |||
Kamran B Lankarani | |||
Maryam Akbari | |||
Naghmeh Mirhosseini | |||
P2860 | cites work | Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection | Q62071826 |
Impaired nocturnal secretion of melatonin in coronary heart disease | Q72262842 | ||
Myocardial ischemia and autonomic activity in dippers and non-dippers with coronary artery disease: assessment of normotensive and hypertensive patients | Q74084632 | ||
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men | Q77423887 | ||
Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study | Q87414585 | ||
Corrections to Report of a Trial of Burch Colposuspension | Q95807350 | ||
Melatonin receptors: molecular biology of a new family of G protein-coupled receptors | Q28257225 | ||
Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study | Q28344233 | ||
The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial | Q33630759 | ||
Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial | Q35559325 | ||
Melatonin: Nature's most versatile biological signal? | Q36525997 | ||
Sleep and circadian rhythms: key components in the regulation of energy metabolism | Q36914056 | ||
Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research | Q37779121 | ||
Melatonin and the metabolic syndrome: physiopathologic and therapeutical implications | Q37847857 | ||
Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects | Q38004964 | ||
Photoperiodic control of seasonal body weight cycles in hamsters | Q39837786 | ||
Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. | Q40536989 | ||
Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. | Q42783953 | ||
Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability | Q43252110 | ||
Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. | Q44426717 | ||
Blood pressure-lowering effect of melatonin in type 1 diabetes | Q44831555 | ||
Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. | Q45255929 | ||
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study | Q46090464 | ||
Melatonin reduces body weight gain and increases nocturnal activity in male Wistar rats. | Q47236891 | ||
Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial | Q47257182 | ||
Effect of melatonin in reducing second-generation antipsychotic metabolic effects: A double blind controlled clinical trial. | Q50494270 | ||
Melatonin attenuates antipsychotic metabolic effects: an eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. | Q50654258 | ||
Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. | Q51493396 | ||
Melatonin Reduces Night Blood Pressure in Patients with Nocturnal Hypertension | Q58855300 | ||
P433 | issue | 3 | |
P921 | main subject | systematic review | Q1504425 |
P304 | page(s) | 202-209 | |
P577 | publication date | 2019-01-15 | |
P1433 | published in | Journal of Human Hypertension | Q15746469 |
P1476 | title | The effects of melatonin supplementation on blood pressure in patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials | |
P478 | volume | 33 |